MedTrace Logo

Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients

NCT02691637 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1450

Last updated 2023-04-18

No results posted yet for this study

Summary

Helicobacter pylori (H. pylori) infection has been associated with a development of atrophic gastritis and intestinal metaplasia. H. pylori related atrophic gastritis and intestinal metaplasia have been regarded as pre-malignant lesion. However, the role of H. pylori eradication treatment in the reversibility of atrophic gastritis and intestinal metaplasia has not been clearly defined. The aim of the present study was to investigate the relationship between H. pylori eradication and the reversibility of atrophic gastritis and intestinal metaplasia in Korean patients.

Conditions

  • Helicobacter Pylori Infection
  • Atrophic Gastritis
  • Intestinal Metaplasia

Sponsors & Collaborators

  • National Clinical Research Coordination Center, Seoul, Korea

    collaborator OTHER_GOV

  • Seoul National University Bundang Hospital

    lead OTHER

Principal Investigators

  • Officials Officials, Officials · Seoul National University Bundang Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2022-01-31
Completion
2022-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02691637 on ClinicalTrials.gov